Associated Press
Louisiana's new law categorizing two widely used abortion drugs as “controlled dangerous substances” was challenged in a state court lawsuit Thursday by a physician, a pharmacist and others who say the legislation sets up needless, dangerous delays in treatment during medical emergencies. Although there already was a near-total abortion ban in Louisiana, including by medication, the reclassification of the drugs — mifepristone and misoprostol, which have other critical reproductive health care uses — went into effect earlier this month. “Even short delays in accessing misoprostol can be life-threatening for postpartum hemorrhage patients,” says the lawsuit.